Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson's disease

Histone deacetylases (HDACs) are key epigenetic enzymes and emerging drug targets in cancer and neurodegeneration. Pan-HDAC inhibitors provided neuroprotection in Parkinson's Disease (PD) models, however, the HDAC isoforms with highest neuroprotective potential remain unknown. Zebrafish larvae...

ver descrição completa

Detalhes bibliográficos
Autor principal: Brígida R Pinho (author)
Outros Autores: Sara D Reis (author), Pedro Guedes-Dias (author), Ana Leitão-Rocha (author), Clara Quintas (author), Patrícia Valentão (author), Paula B Andrade (author), Miguel M Santos (author), Jorge M.A Oliveira (author)
Formato: article
Idioma:eng
Publicado em: 2016
Assuntos:
Ciências farmacológicas, Neurociências, Ciências da saúde
Pharmacological sciences, Neuroscience, Health sciences
Texto completo:https://hdl.handle.net/10216/105015
País:Portugal
Oai:oai:repositorio-aberto.up.pt:10216/105015

Texto Completo

https://hdl.handle.net/10216/105015

Registos relacionados